CSL Limited

BRSE:CSJ Stock Report

Market Cap: CHF 78.2b

CSL Valuation

Is CSJ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CSJ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CSJ (CHF158.89) is trading below our estimate of fair value (CHF251.96)

Significantly Below Fair Value: CSJ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CSJ?

Key metric: As CSJ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CSJ. This is calculated by dividing CSJ's market cap by their current earnings.
What is CSJ's PE Ratio?
PE Ratio32.8x
EarningsUS$2.64b
Market CapUS$85.77b

Price to Earnings Ratio vs Peers

How does CSJ's PE Ratio compare to its peers?

The above table shows the PE ratio for CSJ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average31.1x
LONN Lonza Group
70.3x21.2%CHF 40.3b
NOVN Novartis
17x7.1%CHF 181.9b
ROG Roche Holding
20x10.4%CHF 214.7b
REGN Regeneron Pharmaceuticals
17x9.8%US$78.6b
CSJ CSL
32.8x13.0%CHF 138.3b

Price-To-Earnings vs Peers: CSJ is expensive based on its Price-To-Earnings Ratio (32.8x) compared to the peer average (30.9x).

Price to Earnings Ratio vs Industry

How does CSJ's PE Ratio compare vs other companies in the European Biotechs Industry?

5 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CSJ 32.8xIndustry Avg. 28.9xNo. of Companies5PE020406080100+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CSJ is expensive based on its Price-To-Earnings Ratio (32.8x) compared to the European Biotechs industry average (28.9x).

Price to Earnings Ratio vs Fair Ratio

What is CSJ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CSJ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CSJ's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CSJ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
CHF 191.01
0%
5.8%CHF 209.89CHF 167.70n/a15
Jan ’26n/a
CHF 191.02
0%
5.9%CHF 208.95CHF 166.95n/a15
Dec ’25n/a
CHF 190.55
0%
5.9%CHF 204.87CHF 163.69n/a15
Nov ’25n/a
CHF 187.53
0%
6.3%CHF 202.00CHF 159.19n/a15
Oct ’25n/a
CHF 182.59
0%
6.4%CHF 202.11CHF 155.45n/a14
Sep ’25n/a
CHF 178.30
0%
9.6%CHF 197.76CHF 128.49n/a15
Aug ’25n/a
CHF 183.09
0%
9.6%CHF 208.67CHF 132.03n/a15
Jul ’25n/a
CHF 184.88
0%
8.2%CHF 199.20CHF 136.48n/a16
Jun ’25n/a
CHF 185.25
0%
8.2%CHF 201.78CHF 138.24n/a16
May ’25CHF 163.97
CHF 182.66
+11.4%
9.4%CHF 202.58CHF 138.91n/a16
Apr ’25n/a
CHF 178.30
0%
9.0%CHF 200.22CHF 136.70n/a16
Mar ’25CHF 163.54
CHF 173.89
+6.3%
9.0%CHF 193.11CHF 133.48n/a16
Feb ’25CHF 167.07
CHF 181.44
+8.6%
6.3%CHF 198.67CHF 156.86n/a15
Jan ’25n/a
CHF 179.32
0%
4.3%CHF 199.50CHF 167.80n/a16
Dec ’24n/a
CHF 180.24
0%
4.1%CHF 202.23CHF 170.09n/a16
Nov ’24n/a
CHF 187.78
0%
4.8%CHF 209.67CHF 174.24n/a16
Oct ’24n/a
CHF 192.30
0%
4.0%CHF 211.45CHF 175.72n/a16
Sep ’24n/a
CHF 184.65
0%
5.8%CHF 203.77CHF 152.60n/a18
Aug ’24n/a
CHF 188.47
0%
6.2%CHF 204.29CHF 151.39n/a18
Jul ’24n/a
CHF 195.47
0%
6.2%CHF 209.17CHF 154.89n/a18
Jun ’24n/a
CHF 207.72
0%
6.9%CHF 222.05CHF 156.53n/a18
May ’24n/a
CHF 204.48
0%
7.1%CHF 218.11CHF 153.76CHF 163.9717
Apr ’24n/a
CHF 209.25
0%
7.0%CHF 224.09CHF 158.10n/a17
Mar ’24n/a
CHF 216.45
0%
7.1%CHF 230.42CHF 162.57CHF 163.5417
Feb ’24n/a
CHF 203.81
0%
7.7%CHF 223.94CHF 161.11CHF 167.0716
Jan ’24n/a
CHF 199.58
0%
6.4%CHF 217.26CHF 165.56n/a16

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 01:52
End of Day Share Price 2024/12/13 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CSL Limited is covered by 29 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Saul HadassinBarrenjoey Markets Pty Limited
Thomas WakimBell Potter